BioSuspensions is among the finalists to present their technology at the Royal Society of Chemistry’s flagship event, “Chemistry Means Business” on 15th October at QEII …
Read more
BioSuspensions
Interested in investing in BioSuspensions?
We’re seeking investors to help take our SpheruLUGOL™ equine wound dressing through its next stage of development and explore the wider potential of SpheruliTEK™.
Have a formulation challenge?
Whether you’re working on a poorly soluble drug or exploring a new application, let’s discuss what SpheruliTEK™ could make possible.